Idiopathic inflammatory myopathies (IIM), also known as myositis, are a heterogeneous
group of autoimmune disorders with varying clinical manifestations, treatment responses …

Background In 2012, a European initiative called S ingle H ub and A ccess point for pediatric
R heumatology in E urope (SHARE) was launched to optimise and disseminate diagnostic …

Background Idiopathic inflammatory myopathy (IIM) is a multi-system autoimmune condition
characterised by muscle inflammation (myositis), interstitial lung disease (ILD), and skin …

Objective To develop response criteria for adult dermatomyositis (DM) and polymyositis
(PM). Methods Expert surveys, logistic regression, and conjoint analysis were used to …

Objective To ascertain contemporary approaches to the collection, reporting and analysis of
adverse events (AEs) in randomised controlled trials (RCTs) with a primary efficacy …

Primary Sjögren syndrome (pSS) is a progressive autoimmune disease characterized by
sicca and systemic manifestations. In this Review, we summarize the available data on …

As with the treatment of many immune-mediated diseases, managing myositis encompasses
diverse factors, which present a challenge to the physician caring for these patients. The …

The adult and juvenile myositis syndromes, commonly referred to collectively as idiopathic
inflammatory myopathies (IIMs), are systemic autoimmune diseases with the hallmarks of …

Objectives Juvenile myositis is a rare and heterogeneous disease. Diagnosis is often difficult
but early treatment is important in reducing the risk of associated morbidity and poor …

Objective To evaluate the efficacy and safety of Janus kinase inhibitors (JAKis) in JDM.
Methods We conducted a single-centre retrospective study of patients with JDM treated by …